Published in
American Society of Hematology, Blood, 4(126), p. 494-499, 2015
DOI: 10.1182/blood-2015-02-626788
Links
- American Society of Hematology | PDF
- ORCID
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
Tools
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: A matched cohort study
Journal article published in 2015 by
Jessica Donato,
Federico Campigotto,
Erik J. Uhlmann,
Erika Coletti,
Donna Neuberg 
,
Griffin M. Weber,
Jeffrey I. Zwicker
,
Griffin M. Weber,
Jeffrey I. Zwicker
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Significant intracranial hemorrhage occurs in 20% to 50% of patients with metastatic brain tumors. Therapeutic anticoagulation in patients with brain metastasis did not increase the risk for intracranial hemorrhage.